FDA Withdraws Proposed Rule on Iontophoresis Device Identification

Summary

The FDA is withdrawing its proposed rule to remove the class III premarket approval identification for iontophoresis devices, following comments received on the proposal, and is considering alternative actions, while also announcing an opportunity to comment on a potential reclassification of these devices.